Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1992
05/29/1992WO1992008708A1 Biologically active amines
05/29/1992WO1992008701A1 Retroviral protease inhibitors
05/29/1992WO1992008700A1 Retroviral protease inhibitors
05/29/1992WO1992008699A1 Retroviral protease inhibitors
05/29/1992WO1992008698A1 Retroviral protease inhibitors
05/29/1992WO1992008694A1 Aminosulfonyl urea acat inhibitors
05/29/1992WO1992008693A1 Aminosulfonyl carbamates
05/29/1992WO1992008692A1 Oxysulfonyl urea acat inhibitors
05/29/1992WO1992008688A1 Retroviral protease inhibitors
05/29/1992WO1992008474A2 Treatment of lung diseases
05/29/1992WO1992008469A1 Method of reducing weight in mammals
05/29/1992WO1992008468A1 Combinations of anthelmintically active agents
05/29/1992WO1992008467A1 Dispersion preparation
05/29/1992WO1992008466A1 Heparan sulfate biosynthesis primers
05/29/1992WO1992008465A2 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
05/29/1992WO1992008464A1 Substituted urea and related cell adhesion modulation compounds
05/29/1992WO1992008463A1 Direct compression method for preparing pills having cephalosporanic acid derivatives
05/29/1992WO1992008460A1 Bis-dioxopiperazines for treating liver tumours
05/29/1992WO1992008459A1 Topical compositions for transdermal delivery of produg derivatives of morphine
05/29/1992WO1992008458A1 Use of temocillin or carbenicillin for the treatment or prophylaxis of bacterial infections in fish
05/29/1992WO1992008452A1 Use of nabumetone for the treatment of myofascial pain syndrome
05/29/1992WO1992008451A1 Use of nabumetone for treatment of cancer pain
05/29/1992WO1992008450A2 ANTIVIRAL USE OF A 2,6-DI-t-BUTYLPHENOL COMPOUND SUBSTITUTED IN POSITION 4, PARTICULARLY IN RELATION TO HERPESVIRUSES AND PAPILLOMAVIRUSES
05/29/1992WO1992008447A1 Aerosol containing medicaments
05/29/1992WO1992008446A1 Aerosol medicaments
05/29/1992WO1992008442A1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and anti-microbial agent
05/29/1992WO1992008441A1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts
05/29/1992WO1992005172A3 Muscarinic receptor antagonists
05/29/1992CA2095430A1 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
05/29/1992CA2094807A1 Aminosulfonyl carbamates
05/29/1992CA2074729A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation
05/29/1992CA2056311A1 .beta.-hydroxyethylamines having a 1,1-disubstituted cyclopropyl radical,a p process for their preparation and their use
05/29/1992CA2056144A1 Pharmaceutical compounds
05/29/1992CA2056103A1 3-substituted cephalosporins, process for their preparation and their use as medicaments
05/29/1992CA2055530A1 Aryl derivatives
05/28/1992WO1992009618A1 8-ENE-19, 11β-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM
05/28/1992WO1992009606A1 Optically active thiazoloisoindolinone derivatives with an antiviral action
05/28/1992WO1992009287A1 Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections
05/28/1992WO1992009286A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material
05/28/1992CA2097087A1 Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections
05/28/1992CA2097079A1 8-ene-19, 11.bet.beta.-bridged steroids, their preparation and pharma ceutical formulations containing them
05/28/1992CA2096962A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material
05/28/1992CA2095255A1 Optically-active thiazoloisoindolinone derivatives with anti-viral action
05/27/1992WO1992009635A1 Methyl pyrrolidinone chitosan, production process and uses thereof
05/27/1992WO1992009572A1 Anilide derivative
05/27/1992WO1992009283A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same
05/27/1992WO1992009269A1 Oral spiramycine formulations and method for preparing same
05/27/1992EP0487512A1 Production of heterodimeric human fertility hormones
05/27/1992EP0487502A2 Pharmaceutically active aryl-substituted amine derivatives
05/27/1992EP0487423A1 Benzoselenazolinone derivatives, their preparation and pharmaceutical compositions containing them
05/27/1992EP0487411A1 Erythromycin derivatives, their preparation, intermediates obtained and their application as medicaments
05/27/1992EP0487408A1 Oxazolopyridine derivatives, process for their preparation and pharmaceutical compositions comprising the same
05/27/1992EP0487404A1 External dermatological composition
05/27/1992EP0487382A1 Use of buflomedil for the protection of the myocardium by coronary angioplasty
05/27/1992EP0487335A1 Pharmaceutical dosage forms of dihydropyridines
05/27/1992EP0487270A2 HIV protease inhibitors having polyether substituents
05/27/1992EP0487252A1 Quinoline and 1,5-Naphthyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
05/27/1992EP0487207A1 Benzolactam analogs as antagonists of CCK
05/27/1992EP0487097A1 Pyrazoloacridone derivatives
05/27/1992EP0487095A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation
05/27/1992EP0487071A1 Condensed heterocyclic compounds, their production and use
05/27/1992EP0487066A1 Disinfectant composition
05/27/1992EP0486998A1 Slow-releasing composition of platinum-containing anticancer agent
05/27/1992EP0486964A2 S(+)-Phenyl-alkanoic acids and alpha-hydroxy-alkanoic acids containing complexes
05/27/1992EP0486959A1 Pharmaceutical composition of microparticles with controlled release and process of preparing it
05/27/1992EP0486958A1 Physostigmine derivatives
05/27/1992EP0486948A2 Retroviral protease inhibiting compounds
05/27/1992EP0486944A2 Method of inhibiting tumor growth using xanthocillin X dimethylether
05/27/1992EP0486882A1 Substituted anilides
05/27/1992EP0486863A1 Antiacid compositions with prolonged gastric residence time
05/27/1992EP0486809A2 Use of suramin against TNF-related diseases
05/27/1992EP0486806A1 Process for the preparation of racemic pilosinine derivatives
05/27/1992EP0486734A1 1-Aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders
05/27/1992EP0486702A1 Phenyl 4-guanidinobenzoate derivative, process for producing the same, and protease inhibitor containing the same
05/27/1992EP0486671A1 Orally active nonaddicting analgesics
05/27/1992EP0486632A1 Anti-actinic agent.
05/27/1992EP0486561A1 Buccal composition containing s(+) flurbiprofen or ketoprofen.
05/27/1992EP0486529A1 Transdermal nitroglycerin patch with penetration enhancers
05/27/1992EP0486499A1 Stable ascorbic acid compositions.
05/27/1992DE4124333A1 Agent to inhibit inflammation and promote epithelial growth in eyes
05/27/1992DE4037941A1 Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentanetherderivate, processes for their preparation and their pharmaceutical use
05/27/1992DE4037174A1 Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten New sulfonamides, process for their production and pharmaceuticals containing these compounds
05/27/1992CN1061415A Complexes containing s(+) phenyl alkane acids and amino sugars
05/27/1992CN1061414A Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
05/27/1992CN1061413A Pharmaceutical compounds
05/27/1992CN1061411A Quinazolines derivatives for enhancing antitumor
05/27/1992CN1061410A Substituted azoles, process for their preparation, agents containing them and their use
05/27/1992CN1061409A Compounds, pharmaceutical compositions containing them and process for preparing same
05/27/1992CN1061408A Saturated hydroxyalkylquinoline acids as leukotriene antagonists
05/27/1992CN1061407A Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
05/27/1992CN1061405A Complexes containing s(+)-phenyl alkane acids and alpha-hydroxyalkane acids
05/27/1992CN1061404A Complexes containing s(+) phenyl alkane acids and alpha-amino acids
05/27/1992CN1061341A Use of thiazoloisoindolinone derivatives as antiviral medicaments
05/27/1992CN1061340A Semduramicin premix
05/27/1992CN1016785B Azithromycin dihydrate
05/27/1992CN1016784B Process for preparating homodisaccharide hypoglycemic agents
05/27/1992CN1016783B Promoting agent of activity of some antitumor agent against various kinds of tumor cell
05/27/1992CN1016782B Process for preparing 1-ethylol-2-methyl-5-nitroimidazole
05/27/1992CA2096943A1 Oral spiramycine formulations and method for preparing same
05/27/1992CA2074517A1 Methyl pyrrolidinone chitosan, production process and uses thereof